LVAD - Who Needs it?

<p>LVAD – Who Needs It?</p> <p>Guest: Andrew (Drew) N. Rosenbaum, M.D. <a href='https://twitter.com/werDrD'>(@werDrD</a>)</p> <p>Host: Malcolm R. Bell, M.D.</p> <p>About 6.5 million people over the age of 20 years in the U.S. have heart failure. That number is estimated to grow to about 8 million by 2030. Of those patients, about 300,000 would potentially benefit from left ventricular assist device (LVAD) therapy. Among patients with advanced heart failure, 66% to 75% would have comorbidities that would preclude benefit from LVAD therapy, so approximately 75,000 to 100,000 patients in the U.S. would be potentially eligible for LVAD therapy.</p> <p>Joining us today to discuss LVADs is Andrew (Drew) N. Rosenbaum, M.D., a cardiologist at Mayo Clinic in Rochester, Minnesota.</p> <p>Specific topics discussed:</p> <ul><li>Types of left ventricular assist devices: durable, destination therapy, bridge to transplantation</li> <li>Who benefits from LVAD and why</li> <li>LVAD durability</li> <li>Age limitations for LVAD therapy</li> <li>Inappropriate candidates for LVAD</li> <li>End-stage renal disease, LVAD and dialysis</li> <li>When to consider referral for LVAD therapy</li> </ul> <p>Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at <a href='https://cveducation.mayo.edu'>https://cveducation.mayo.edu</a> or on Twitter <a href='https://www.twitter.com/mayocliniccv'>@MayoClinicCV</a>.</p> <p>No CME credit offered for this episode.</p> <p>Podcast episode transcript found <a href='https://mcdn.podbean.com/mf/web/8fim3k/P-MayoCV21_LVAD_Who_Needs_it_Bell-Rosenbaum_CC_Transcript_Final6gn1y.pdf'>here</a>.</p>